Improving Screen Failure and Recruitment Rates in Alzheimer’s Disease Clinical Trials

Predicting the causes for screen failure and how to overcome Alzheimer's recruitment challenges

Read more

The failures of clinical trials in Alzheimer’s disease have been attributed to a variety of factors. This article analyzes ways to improve screen failure and recruitment rates.


Chief Development Officer
Vice President, Scientific Solutions, Neuroscience

Want to learn more about Worldwide Clinical Trials?